Harmony Biosciences Holdings, Inc.
HRMY
$34.10
$1.715.28%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 44.48% | -55.79% | 27.88% | -12.70% | -7.91% |
| Total Depreciation and Amortization | -19.70% | 24.53% | 0.02% | -0.02% | 0.00% |
| Total Amortization of Deferred Charges | -3.82% | -2.48% | -1.23% | -1.81% | -1.78% |
| Total Other Non-Cash Items | 75.98% | 2.04% | 8.42% | 144.28% | 97.27% |
| Change in Net Operating Assets | -167.04% | 145.63% | 123.27% | 152.20% | -263.52% |
| Cash from Operations | -77.99% | 16.02% | 37.07% | 133.40% | -55.02% |
| Capital Expenditure | -- | -50.70% | -1,675.00% | 96.88% | 75.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -947.85% | -271.47% | 75.91% | -886.55% | 137.31% |
| Cash from Investing | -941.49% | -268.20% | 75.55% | -929.34% | 132.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -33.33% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -86.90% | 251.19% | -64.04% | -55.44% | 45.38% |
| Repurchase of Common Stock | -286.88% | -- | 100.00% | 21.02% | 41.29% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -139.40% | -0.63% | -11.54% | -663.07% | 87.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -254.60% | 4.51% | 76.94% | 58.49% | -45.15% |